Longs Merger Plot Thickens (LDG, WAG, CVS)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Longs_logoLongs Drug Stores Corporation (NYSE: LDG) is doing something which may seem odd to many, which is essentially a "going with the bird in the hand" strategy.  The company has just announced that its board of directors has determined not to have buyout discussions with Walgreens (NYSE: WAG).  This was after consultation with its legal and financial advisors.  Walgreens had sent Longs an expression of interest that was announced on September 12.

Longs has decided to proceed with itsmerger offer from CVS Caremark (NYSE: CVS).  There are many reasonscited for this rejection including regulatory concerns, a lack of aroadmap, a lack of shareholder compensation over delays, and theexpression of interest being non-binding.

Longs shares are actually down almost 2% at $75.00 in pre-markettrading.  Here is the issue at hand.  The CVS bid is $71.50 andWalgreens has indicated that it is willing to pay $75.00.  There aresome potential antitrust problems and it is believed by many that arival bid would take much longer into 2009 to close than the CVS offer.

Now it boils down to one thing: Will Walgreens come back with a higher bid that forces Longs’ board of directors to play along?

Jon C. Ogg
September 17, 2008

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

BLDR Vol: 2,244,021
MHK Vol: 688,964
BKNG Vol: 7,749,067
EXPE Vol: 1,655,619
IQV Vol: 943,724

Top Losing Stocks

CTRA Vol: 73,319,495
WDC Vol: 8,092,967
STX Vol: 2,580,801
QCOM Vol: 12,972,968
APO Vol: 3,797,408